[Long-term prevention of MS: effectiveness alone is not enough].
Haas
Judith
J
D004185:Disability Evaluation; D018450:Disease Progression; D000068717:Glatiramer Acetate; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D016899:Interferon-beta / Q000627:therapeutic use; D008134:Long-Term Care; D009103:Multiple Sclerosis / Q000276:immunology / Q000451:nursing* / Q000517:prevention & control; D010455:Peptides / Q000627:therapeutic use; D016896:Treatment Outcome
D007155:Immunologic Factors; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta